In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of EuroPCR 2022.
Which late-breaking science trials could have the most impact on practice? What are the considerations and challenges? What are the latest advances in interventional cardiology?
Trials covered in detail include:
00:53 DECISION QFR: Heart Team decision-making based on angiography-derived FFR
03:22 PROPHET-FFR: Safety and efficacy of post-PCI physiological assessment (NCT05056662)
05:38 Optimize PRO: Impact of standardised TAVI technique and care pathway (NCT04091048)
09:16 Safety & efficacy of 170 Consecutive Patients with Commissural Alignment
10:24 DISCO RADIAL: DIStal vs. COnventional RADIAL access for coronary angiography and intervention (NCT04171570)
12:52 GREECE: CT-guided invasive coronary angiography in patients with CABG (NCT04631809)
15:24 JenaValve Trilogy: First real-world results of the JenaValve TAVI system in aortic stenosis
16:33 FORWARD PRO: Interventional Post-market Study with the Evolut™ PRO System (NCT03417011)
18:57 LYTEN: Balloon vs. self-expanding valves in valve-in-valve TAVI (NCT03520101)
19:43 BASELINE: Three-year outcomes following TAVI with a self-expanding valve with pericardial wrap (NCT04843072)